Multiple Myeloma and Plasma Cell Neoplasm

Showing NaN - NaN of 24

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)

Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021

Multiple Myeloma and Plasma Cell Tumor Trial in United States (arsenic trioxide)

Terminated
  • Multiple Myeloma and Plasma Cell Neoplasm
  • arsenic trioxide
  • La Jolla, California
  • +5 more
Oct 2, 2020

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

Withdrawn
  • Leukemia
  • +4 more
  • alemtuzumab
  • +6 more
  • La Jolla, California
  • +23 more
Nov 25, 2019

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in United States (cyclosporine ophthalmic emulsion, )

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • cyclosporine ophthalmic emulsion
  • placebo
  • Palo Alto, California
  • +4 more
Jan 24, 2017

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Chicago, Iowa City, Winston-Salem (Compound 506U78)

Terminated
  • Chronic Myeloproliferative Disorders
  • +4 more
  • Compound 506U78
  • Chicago, Illinois
  • +2 more
Jul 1, 2016

Multiple Myeloma and Plasma Cell Tumor Trial in Puerto Rico, South Africa, United States (dexamethasone, pamidronate disodium,

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Scottsdale, Arizona
  • +77 more
Apr 2, 2014

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Chicago (biological, drug, procedure)

Completed
  • Leukemia
  • +3 more
  • anti-thymocyte globulin
  • +3 more
  • Chicago, Illinois
    University of Chicago Cancer Research Center
Mar 6, 2014

Multiple Myeloma and Plasma Cell Tumor Trial in Chicago (biological, drug, procedure)

Unknown status
  • Multiple Myeloma and Plasma Cell Neoplasm
  • filgrastim
  • +7 more
  • Chicago, Illinois
  • +1 more
Jan 3, 2014

Multiple Myeloma and Plasma Cell Tumor Trial in United States (ascorbic acid, bortezomib, melphalan)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • ascorbic acid
  • +2 more
  • Fresno, California
  • +7 more
Nov 5, 2013

Multiple Myeloma and Plasma Cell Tumor Trial in Canada, United States (dexamethasone, doxorubicin HCl, valspodar)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • La Jolla, California
  • +39 more
Aug 28, 2013

Multiple Myeloma and Plasma Cell Tumor Trial in United States (semaxanib)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Tampa, Florida
  • +3 more
Jul 10, 2013

Anemia, Leukemia, Lymphoma Trial in United States (epoetin alfa, quality-of-life assessment)

Completed
  • Anemia
  • +3 more
  • epoetin alfa
  • quality-of-life assessment
  • Berkeley, California
  • +17 more
Jul 1, 2013

Multiple Myeloma and Plasma Cell Tumor Trial in United States (bevacizumab, thalidomide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Duarte, California
  • +3 more
Jun 20, 2013

Chronic Myeloproliferative Disorders, Infection, Leukemia Trial in United States (amphotericin B deoxycholate, nystatin)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • Phoenix, Arizona
  • +58 more
Mar 25, 2013

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Chicago (tipifarnib)

Completed
  • Chronic Myeloproliferative Disorders
  • +4 more
  • Chicago, Illinois
    University of Chicago Cancer Research Center
Feb 8, 2013

Chronic Myeloproliferative Disorders, Leukemia, Multiple Myeloma and Plasma Cell Tumor Trial in Chicago (drug, procedure,

Completed
  • Chronic Myeloproliferative Disorders
  • +2 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Jun 8, 2012

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Chicago (allogeneic Epstein-Barr virus-specific cytotoxic T

Completed
  • Leukemia
  • +2 more
  • allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes
  • autologous Epstein-Barr virus-specific cytotoxic T lymphocytes
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
May 31, 2012

Multiple Myeloma and Plasma Cell Tumor Trial in Chicago (biological, drug, procedure)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • filgrastim
  • +2 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center, Northwestern Univer
May 31, 2012

Breast Cancer, Leukemia, Lymphoma Trial in Chicago (filgrastim, recombinant flt3 ligand, recombinant human thrombopoietin)

Completed
  • Breast Cancer
  • +4 more
  • filgrastim
  • +4 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center, Northwestern Univer
May 31, 2012

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Chicago (biological, drug, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +7 more
  • anti-thymocyte globulin
  • +8 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center, Northwestern Univer
May 31, 2012

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Chicago (biological, drug, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • filgrastim
  • +5 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center, Northwestern Univer
May 31, 2012

Multiple Myeloma and Plasma Cell Tumor Trial in Chicago (tocladesine)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center, Northwestern Univer
May 17, 2012

Multiple Myeloma and Plasma Cell Tumor Trial in Chicago, Cleveland (O6-benzylguanine, carmustine)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Chicago, Illinois
  • +2 more
Jun 9, 2010